Endocyte is currently sponsoring clinical trials related to several oncology product candidates. Click the links below for details on each study.

EC145: Folate-Receptor Targeted Chemotherapy

• Phase 2 PRECEDENT trial for patients with platinum-resistant ovarian cancer: currently recruiting participants.
• Phase 2 trial for patients with non-small cell lung cancer (NSCLC): enrollment complete.
• Phase 2 trial for patients with ovarian cancer: enrollment complete.

EC17: Folate-Receptor Targeted Hapten

• Phase 1 renal (kidney) cell carcinoma trial: enrollment complete.

EC0225: Folate-Receptor Targeted  Chemotherapy

• Phase 1 solid tumor trial: currently recruiting participants.

EC0489: Folate-Receptor Targeted Chemotherapy

• Phase 1 solid tumor trial: currently recruiting participants.

Medical professionals requiring additional information may contact clinical@endocyte.com.

Relevant Publications

• EC145: ASCO 2007 Annual Meeting
• EC17: ASCO 2007 Annual Meeting